Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion type Assertion NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_head.
- NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion description "[The use of FASN inhibitors has been limited until now by anorexia and weight loss, which is associated with the stimulation of fatty acid oxidation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_provenance.
- NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion evidence source_evidence_literature NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_provenance.
- NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion SIO_000772 19189648 NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_provenance.
- NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion wasDerivedFrom befree-20140225 NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_provenance.
- NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion wasGeneratedBy ECO_0000203 NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_provenance.